Molecule of the Week
May 9, 2011
Dolasetron, available commercially as Anzement, is an anti-emetic drug that is especially useful to chemotherapy patients. Its mode of action is as a serotonin 5-HT3 receptor antagonist. A new, more scalable synthetic route to dolasteron was featured in a recent Patent Watch report.
More about this molecule from CAS, the most authoritative and comprehensive source for chemical information.